FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:276-278 July 22, 1993 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Lee, J. M.

To the Editor: In discussing screening and informed consent (Feb. 11 issue),¹ Dr. Lee failed to mention the development of more sensitive screening techniques capable of achieving reductions in mortality not seen in clinical trials of 10 to 30 years ago. The consensus is that mammographic screening for breast cancer can now reduce mortality by as much as 30 percent.

Physicians have turned to major health organizations such as the American Cancer Society and the National Cancer Institute for guidelines regarding the early detection of cancer. Guidelines, when promulgated, are a product of the most valid and current research and . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.